Who should not take DNSP-11?
Documented caution flags for DNSP-11 include active psychiatric medication regimen affecting dopamine and pregnancy / nursing. This is not exhaustive, and absence from this list is not a safety clearance. Anyone pregnant, nursing, or managing a serious medical condition should only consider it under a doctor's care, and safety data for DNSP-11 is limited.
Documented caution flags for DNSP-11
- Active psychiatric medication regimen affecting dopamine
- Pregnancy / nursing
- Anyone risk-averse to pre-clinical compounds
Reported side effects to weigh
- Limited human safety data
- Theoretical effects on dopaminergic signaling
- Injection-site irritation
References
- Dopamine neuron stimulating actions of a GDNF propeptide — Bradley LH, Fuqua J, Richardson A, et al. (Gerhardt GA group). PLoS One, 2010
- Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques — Stenslik MJ, Evans A, Pomerleau F, et al. (Gerhardt GA, Bradley LH groups). Journal of Neuroscience Methods, 2018
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on DNSP-11
Last updated 2026-06-15.